- Home
- LPCN vs GELS Comparison
LPCN vs GELS Comparison
Compare LPCN & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- GELS
- Stock Information
- Founded
- LPCN 1997
- GELS 2018
- Country
- LPCN United States
- GELS Australia
- Employees
- LPCN N/A
- GELS N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- GELS
- Sector
- LPCN Health Care
- GELS
- Exchange
- LPCN Nasdaq
- GELS NYSE
- Market Cap
- LPCN 19.4M
- GELS 19.9M
- IPO Year
- LPCN N/A
- GELS 2024
- Fundamental
- Price
- LPCN $3.38
- GELS $1.92
- Analyst Decision
- LPCN Strong Buy
- GELS
- Analyst Count
- LPCN 1
- GELS 0
- Target Price
- LPCN $10.00
- GELS N/A
- AVG Volume (30 Days)
- LPCN 33.0K
- GELS 51.9K
- Earning Date
- LPCN 03-06-2025
- GELS 02-15-2025
- Dividend Yield
- LPCN N/A
- GELS N/A
- EPS Growth
- LPCN N/A
- GELS N/A
- EPS
- LPCN N/A
- GELS N/A
- Revenue
- LPCN $7,922,926.00
- GELS $95,618.00
- Revenue This Year
- LPCN N/A
- GELS N/A
- Revenue Next Year
- LPCN N/A
- GELS N/A
- P/E Ratio
- LPCN N/A
- GELS N/A
- Revenue Growth
- LPCN N/A
- GELS N/A
- 52 Week Low
- LPCN $3.20
- GELS $1.42
- 52 Week High
- LPCN $11.79
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- LPCN 30.99
- GELS N/A
- Support Level
- LPCN $3.42
- GELS N/A
- Resistance Level
- LPCN $3.62
- GELS N/A
- Average True Range (ATR)
- LPCN 0.26
- GELS 0.00
- MACD
- LPCN -0.02
- GELS 0.00
- Stochastic Oscillator
- LPCN 1.61
- GELS 0.00
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.